Synta Pharmaceuticals to Participate in the RBC Capital Markets Healthcare Conference

Health and Fitness Health and Fitness

Tue, December 16, 2008

[ Tue, Dec 16th 2008 ] - Market Wire

Positron Corporation Announces Appointment of Medical Director

[ Tue, Dec 16th 2008 ] - Market Wire

Non-Invasive Stool-Based DNA Screening for Colon .. ancer Recognized More Broadly as Standard of Care

[ Tue, Dec 16th 2008 ] - Market Wire

OSI Pharmaceuticals Announces the Appointment of .. cutive Vice President and Chief Financial Officer

[ Tue, Dec 16th 2008 ] - Market Wire

Obagi Medical Products Expands Partnership with Japan-Based Rohto Pharmaceutical Co., Ltd.

[ Tue, Dec 16th 2008 ] - Market Wire

Tongjitang Chinese Medicines Company Appoints Charles Wang as Chief Financial Officer

[ Tue, Dec 16th 2008 ] - Market Wire

BLADE Network Technologies: Data Center Networkin .. logies Maintains Dominance in Blade Server Switch

[ Tue, Dec 16th 2008 ] - Market Wire

Clinical Data, Inc. Reaffirms Support for Current Regulation of Laboratory-Developed Tests

[ Tue, Dec 16th 2008 ] - Market Wire

BioSante Pharmaceuticals Secures Committed Equity Financing Facility

[ Tue, Dec 16th 2008 ] - Market Wire

Myriad Genetics: Myriad Genetics, Inc. Receives A .. w York Stock Exchange to Proceed With New Listing

[ Tue, Dec 16th 2008 ] - Market Wire

Akorn, Inc. Responds to FDA Draft Guidance for In .. Bioequivalence Recommendation for Vancomycin HCl

[ Tue, Dec 16th 2008 ] - Market Wire

Schiff Nutrition International, Inc. Announces Fiscal 2009 Second Quarter Results

Mon, December 15, 2008

[ Mon, Dec 15th 2008 ] - Market Wire

Diagnos Inc.: DIAGNOS Acquires Four New Mining Properties in the Gaspesie Region

[ Mon, Dec 15th 2008 ] - Market Wire

MDRNA, Inc.: MDRNA, Inc. Announces Tentative FDA .. ic Calcitonin-Salmon Nasal Spray for Osteoporosis

[ Mon, Dec 15th 2008 ] - Market Wire

William S. Shanahan Joins Board of Directors of Life Technologies Corporation

[ Mon, Dec 15th 2008 ] - Market Wire

Celsion Corporation Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox

[ Mon, Dec 15th 2008 ] - Market Wire

Lannett Announces Launch of Two Products

[ Mon, Dec 15th 2008 ] - Market Wire

RTI Biologics, ENTrigue Surgical Announce Develop .. Supply Agreement For Tutoplast -Processed Tissues

[ Mon, Dec 15th 2008 ] - Market Wire

Aetna to Hold Conference Call with Investors

[ Mon, Dec 15th 2008 ] - Market Wire

Pediatrix Acquires Tampa Bay Maternal Fetal Group Practice

[ Mon, Dec 15th 2008 ] - Market Wire

BioDelivery Sciences Submits REMS for ONSOLIS to FDA for Approval

[ Mon, Dec 15th 2008 ] - Market Wire

Illumina Appoints Mark Lewis Senior Vice President of Development

[ Mon, Dec 15th 2008 ] - Market Wire

FORTIS: Fortis statement on the ruling by the Court of Appeal in Brussels

Sun, December 14, 2008

[ Sun, Dec 14th 2008 ] - Market Wire

Abraxis BioScience Launches Abraxane in European Union

[ Sun, Dec 14th 2008 ] - Market Wire

Santarus Announces Strategic Collaboration with C .. S. Rights to Budesonide MMX and Rifamycin SV MMX

Fri, December 12, 2008

[ Fri, Dec 12th 2008 ] - Market Wire

New Data Demonstrate Significant Improvement in P .. Triple Negative Metastatic Breast Cancer Patients

[ Fri, Dec 12th 2008 ] - Market Wire

Alliance Imaging Schedules Conference Call and Webcast to Review Full Year 2009 Financial Guidance

[ Fri, Dec 12th 2008 ] - Market Wire

Gilead Sciences Files Patent Infringement Lawsuit Against Teva Pharmaceuticals

[ Fri, Dec 12th 2008 ] - Market Wire

Court Denies Hi-Tech Pharmacal s Motion Regardin .. amide and Timolol Ophthalmic Solution Exclusivity

[ Fri, Dec 12th 2008 ] - Market Wire

Humana Announces Date of 2009 Annual Stockholders Meeting

[ Fri, Dec 12th 2008 ] - Market Wire

Aeolus Pharmaceuticals Announces Fiscal Year 2008 Financial Results

[ Fri, Dec 12th 2008 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics Announces Clinic .. ding Ispinesib Presented at the 31st Annual San A

[ Fri, Dec 12th 2008 ] - Market Wire

Novelos Therapeutics Announces Presentation of Po .. se 2 Neoadjuvant Breast Cancer Trial at San Anton

[ Fri, Dec 12th 2008 ] - Market Wire

VIVUS Initiates Avanafil Phase 3 Trials

[ Fri, Dec 12th 2008 ] - Market Wire

Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs

Thu, December 11, 2008

[ Thu, Dec 11th 2008 ] - Market Wire

Elan Announces Resource Realignment

[ Thu, Dec 11th 2008 ] - Market Wire

KCI Files New Patent Infringement Claims Against Smith & Nephew

[ Thu, Dec 11th 2008 ] - Market Wire

Announcement by Progenics Pharmaceuticals under Nasdaq Marketplace Rules

[ Thu, Dec 11th 2008 ] - Market Wire

BioMimetic Therapeutics, Inc. Achieves Patient En .. th American Pivotal Study for Augment " Bone Graf

[ Thu, Dec 11th 2008 ] - Market Wire

Spectranetics Quick-Cross Extreme Product Line Receives FDA Clearance

[ Thu, Dec 11th 2008 ] - Nelson Thibodeaux

Youthfulness is Latest American Obsession. New An .. Protocol is Unique in Cosmetic Recovery Industry

[ Thu, Dec 11th 2008 ] - Market Wire

Mannatech Hosts Korean National Convention

[ Thu, Dec 11th 2008 ] - Market Wire

RegeneRx Secures $3 Million in Private Financing

[ Thu, Dec 11th 2008 ] - Market Wire

BioReference Laboratories, Inc. Announces Earning .. Fourth Quarter and Year End for Fiscal Year 2008

[ Thu, Dec 11th 2008 ] - Market Wire

Aetna Re-Enters Delaware Small-Group Market

[ Thu, Dec 11th 2008 ] - Market Wire

Qnexa Meets Primary Endpoint by Demonstrating Sup .. ents and Placebo in the 28-Week Equate Study (OB-

Wed, December 10, 2008

[ Wed, Dec 10th 2008 ] - Market Wire

PPD Announces 2009 Financial Guidance Webcast and Conference Call

[ Wed, Dec 10th 2008 ] - Market Wire

Panacos Provides Update on Corporate Strategy

[ Wed, Dec 10th 2008 ] - James Betz

Biotivia is the first supplement company to utili .. technology to protect resveratrol from oxidation.

[ Wed, Dec 10th 2008 ] - Market Wire

Symbollon Pharmaceuticals, Inc.: Symbollon Enters .. ement Covering Upper Respiratory Tract Technology

[ Wed, Dec 10th 2008 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Completes Clinica .. r AppyScore, World's First Blood-Based Diagnostic

[ Wed, Dec 10th 2008 ] - Market Wire

Lakeland Industries, Inc.: Lakeland Industries, I .. ports Fiscal 2009 Third Quarter Financial Results

[ Wed, Dec 10th 2008 ] - Market Wire

Seattle Genetics Announces Interim Safety Analysi .. ntinuation of Lintuzumab Phase IIb Clinical Trial

[ Wed, Dec 10th 2008 ] - Market Wire

OR-Live, Inc.: REMINDER: OR-Live.com Presents: Ea .. ment of Mitral Valve Disease: Clinical Guidelines

[ Wed, Dec 10th 2008 ] - Market Wire

Viel versprechende Ergebnisse aus zwei Studien zu .. twicklung befindlichen, oralen IMiDS -Pr parats P

[ Wed, Dec 10th 2008 ] - Market Wire

Veelbelovende resultaten uit twee onderzoeken bet .. menstelling pomalidomide gepresenteerd tijdens de

[ Wed, Dec 10th 2008 ] - Market Wire

Risultati promettenti di due studi del composto I .. lidomide, sono presentati alla riunione dell'Amer

Tue, December 9, 2008

[ Tue, Dec 09th 2008 ] - Market Wire

CombinatoRx Presents New Data on B-Cell Malignancy Programs

[ Tue, Dec 09th 2008 ] - Market Wire

Des donn es actualis es portant sur le REVLIMID .. my lome multiple r cemment diagnostiqu font tat

[ Tue, Dec 09th 2008 ] - Market Wire

Curves International and Healthways SilverSneakers Fitness Program Announce Partnership

[ Tue, Dec 09th 2008 ] - Market Wire

Cavit Sciences, Inc.: Cavit Sciences Is Now in the Hands of the Shareholders and Moving Forward

[ Tue, Dec 09th 2008 ] - Market Wire

Stellar Pharmaceuticals Inc.: Stellar Pharmaceuti .. eement For Distribution and Sale of Uracyst(R) in

[ Tue, Dec 09th 2008 ] - Market Wire

Presentazione all'ASH di uno studio di fase I su .. e SMD ad alto rischio riporta che la combinazione

[ Tue, Dec 09th 2008 ] - Market Wire

Dyloject " Significantly Reduces Moderate-to-Seve .. Pain in Pivotal Phase 3 Orthopedic Surgical Trial

[ Tue, Dec 09th 2008 ] - Market Wire

Geactualiseerde REVLIMID -gegevens bij pas gediag .. maken melding van nooit geziene overlevingspercen

[ Tue, Dec 09th 2008 ] - Market Wire

Molina Healthcare Renews and Replaces Its Universal Shelf Registration Statement

[ Tue, Dec 09th 2008 ] - Market Wire

AngioDynamics Appoints Vice President, Regulatory, Quality and Clinical Affairs

Mon, December 8, 2008

[ Mon, Dec 08th 2008 ] - Market Wire

Bio-Imaging Technologies Partners with AG Mednet .. fer Complete Imaging Solution for Clinical Trials

[ Mon, Dec 08th 2008 ] - Market Wire

Neoprobe Achieves Final Milestone in $13 Million .. sitive Phase 3 Breast Cancer and Melanoma Results

[ Mon, Dec 08th 2008 ] - Market Wire

Data from Pivotal Study Show Medtronic Deep Brain .. ced Seizure Rate in Patients with Severe Epilepsy

[ Mon, Dec 08th 2008 ] - Market Wire

ZIOPHARM Presents Positive Darinaparsin Phase II Data at ASH Meeting

[ Mon, Dec 08th 2008 ] - Market Wire

Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. sent at RBC Capital Markets Healthcare Conference

[ Mon, Dec 08th 2008 ] - Market Wire

Bristol-Myers Squibb and AstraZeneca Announce Exp .. tion to Develop and Commercialize Dapagliflozin i

[ Mon, Dec 08th 2008 ] - Market Wire

Relazione su due presentazioni ASH: Attivit e t .. in pazienti con leucemia linfocitica cronica sin

[ Mon, Dec 08th 2008 ] - Market Wire

Emergent BioSolutions to Webcast Presentation at .. ealthcare Conference on Wednesday, January 14, 20

[ Mon, Dec 08th 2008 ] - Market Wire

Cytori Demonstrates Benefit of Adipose-Derived St .. Cells in Spinal Disc Repair in Preclinical Study

[ Mon, Dec 08th 2008 ] - Market Wire

ImmunoGen, Inc. Announces Genentech s Fifth TAP Technology License

Sun, December 7, 2008

[ Sun, Dec 07th 2008 ] - Market Wire

Crucell N.V.: Crucell Announces Registration of Hepavax-Gene(R) in China

[ Sun, Dec 07th 2008 ] - Market Wire

Exelixis Reports Phase 1 Data for XL019 at ASH Annual Meeting

[ Sun, Dec 07th 2008 ] - Market Wire

ARIAD To Hold Conference Call on Monday Morning, December 8, 2008

[ Sun, Dec 07th 2008 ] - Market Wire

Allos Therapeutics Announces Top Line Results fro .. l of Pralatrexate in Patients with Relapsed or Re

Sat, December 6, 2008

[ Sat, Dec 06th 2008 ] - Market Wire

Seattle Genetics Reports Objective Responses with .. acetuzumab in Phase II Non-Hodgkin Lymphoma Trial

Fri, December 5, 2008

[ Fri, Dec 05th 2008 ] - Market Wire

Health Net and the USO of Metropolitan Washington Team Up for Annual Celebration of Children

[ Fri, Dec 05th 2008 ] - Market Wire

Coventry Health Care Appoints Allen Wise as Executive Chairman

[ Fri, Dec 05th 2008 ] - Market Wire

KV Pharmaceutical Announces Changes in Senior Management

[ Fri, Dec 05th 2008 ] - Market Wire

CytoCore CEO Continues to Purchase Shares of CYOE in the Open Market

[ Fri, Dec 05th 2008 ] - Market Wire

Ore Pharmaceuticals Announces Completion of Multi .. inical Phase 1 Trial; Presents GL1001 Preclinical

[ Fri, Dec 05th 2008 ] - Market Wire

Company Profile for Alphatec Spine

[ Fri, Dec 05th 2008 ] - Market Wire

Candela to Seek Stockholder Approval Prior to Certain Issuances of Preferred Stock

[ Fri, Dec 05th 2008 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics Announces Precli .. a Regarding Ispinesib to Be Presented at the 31st

[ Fri, Dec 05th 2008 ] - Market Wire

St. Jude Medical Announces Neuromodulation Divisi .. rand Identity at 12th Annual North American Neuro

[ Fri, Dec 05th 2008 ] - Market Wire

Resumen: Publicados en el New England Journal of .. an la eficacia de Viread en el tratamiento de la

Thu, December 4, 2008

[ Thu, Dec 04th 2008 ] - Market Wire

AmSurg Corp. to Present at the RBC Capital Markets 2008 Healthcare Conference

[ Thu, Dec 04th 2008 ] - Market Wire

SCOR: Moody's upgrades SCOR to 'A2'

[ Thu, Dec 04th 2008 ] - Market Wire

Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

[ Thu, Dec 04th 2008 ] - Market Wire

Novelos Therapeutics and Academic Collaborators P .. Posters at 2008 AACR Tumor Immunology Conference

[ Thu, Dec 04th 2008 ] - Market Wire

Tesetaxel, a Leading Oral Taxane in Clinical Deve .. ation as an Orphan Drug for Treatment of Patients

[ Thu, Dec 04th 2008 ] - Market Wire

BioSante Pharmaceuticals Signs Elestrin " Marketing Agreement with Azur Pharma

[ Thu, Dec 04th 2008 ] - Market Wire

Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on December 9, 2008

[ Thu, Dec 04th 2008 ] - Market Wire

ImmunoGen, Inc. Announces Webcast of Panel Sessio .. he RBC Capital Markets 2008 Healthcare Conference

[ Thu, Dec 04th 2008 ] - Market Wire

Sirona Announces $50 Million Share Repurchase Authorization

[ Thu, Dec 04th 2008 ] - Market Wire

Centene Corporation Names Aaron W. Brace as President and CEO of South Carolina Subsidiary

Wed, December 3, 2008

[ Wed, Dec 03rd 2008 ] - Market Wire

Alphatec Spine to Present at the RBC Healthcare Conference

[ Wed, Dec 03rd 2008 ] - Market Wire

Zila to Report Fiscal 2009 First Quarter Financia .. s and Host Investor Conference Call on December 8

[ Wed, Dec 03rd 2008 ] - Market Wire

CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases

[ Wed, Dec 03rd 2008 ] - Market Wire

Aspect Medical Systems Repurchases $35 Million of Its 2.5% Convertible Senior Notes Due 2014

[ Wed, Dec 03rd 2008 ] - Market Wire

Synta Pharmaceuticals to Participate in the RBC Capital Markets Healthcare Conference

[ Wed, Dec 03rd 2008 ] - Market Wire

Oscient Pharmaceuticals Receives Paragraph IV Certification Notice for ANTARA

[ Wed, Dec 03rd 2008 ] - Market Wire

Protherics PLC: Offer Update

[ Wed, Dec 03rd 2008 ] - Market Wire

Celgene Corporation and Acceleron Pharma to Prese .. nnual Meeting of the American Society of Hematolo

[ Wed, Dec 03rd 2008 ] - Market Wire

Results of Studies of Eslicarbazepine Acetate for .. Be Presented at American Epilepsy Society Annual

[ Wed, Dec 03rd 2008 ] - Market Wire

Zacks Bull and Bear of the Day Highlights: ViroPh .. s, Union Pacific, Methanex and L-3 Communications

Tue, December 2, 2008

[ Tue, Dec 02nd 2008 ] - Market Wire

Dr. Edmund Pezalla Named President of the Pharmacy and Therapeutics Society

[ Tue, Dec 02nd 2008 ] - Market Wire

Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. Research Institute (NNRI) Collaborate to Test Flu

[ Tue, Dec 02nd 2008 ] - Market Wire

LHC Group Expands Footprint to 16 States with Initial Entry into Oklahoma

[ Tue, Dec 02nd 2008 ] - Market Wire

Metabolic Research, Inc. Expands Broadcast Programs

[ Tue, Dec 02nd 2008 ] - Market Wire

Targeted Genetics: Targeted Genetics Realigns Pro .. Priorities and Implements Cost Reduction Measures

[ Tue, Dec 02nd 2008 ] - Market Wire

Protalix BioTherapeutics Announces Completion of .. votal Phase III Clinical Trial of Gaucher Disease

[ Tue, Dec 02nd 2008 ] - Market Wire

Oculus Innovative Sciences Announces Agreement wi .. Development of Microcyn Technology Use in Taiwa

[ Tue, Dec 02nd 2008 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Cuts Quarterly Fixed Costs by $2 Million or 20 Percent

[ Tue, Dec 02nd 2008 ] - Market Wire

VIVUS to Present at J.P. Morgan 2008 SMid Cap Conference

[ Tue, Dec 02nd 2008 ] - Market Wire

Titan Pharmaceuticals Announces Reduction in Force

Mon, December 1, 2008

[ Mon, Dec 01st 2008 ] - Market Wire

Chembio Diagnostics, Inc.: Chembio Donates HIV Te .. to Support World AIDS Day 2008 Testing Initiative

[ Mon, Dec 01st 2008 ] - Market Wire

DIANOR RESOURCES INC.: Dianor Resources Signs Def .. ition of Surface Rights to Leadbetter Extension P

[ Mon, Dec 01st 2008 ] - Market Wire

FONAR Corporation: FONAR Granted Continued Listing by NASDAQ Panel

[ Mon, Dec 01st 2008 ] - Market Wire

OptumHealth Launches Consumer-Focused Health Info .. pon Its Expertise in Serving 60 Million Americans

[ Mon, Dec 01st 2008 ] - Market Wire

DexComTM Receives CE Mark Approval for the SEVEN Continuous Glucose Monitoring System

[ Mon, Dec 01st 2008 ] - Market Wire

Del Medical Systems Group Launches TITAN Family of Digital Radiographic Systems

[ Mon, Dec 01st 2008 ] - Market Wire

SonoSite Announces the New S-GYN "

[ Mon, Dec 01st 2008 ] - Market Wire

Acorda Therapeutics Elects John P. Kelley to Board of Directors

[ Mon, Dec 01st 2008 ] - Market Wire

Spectrum Pharmaceuticals to Host Conference Call .. ling ZEVALIN Joint Venture and Near-Term Strategy

[ Mon, Dec 01st 2008 ] - Market Wire

Pluristem Retains KKS as Its CRO for Upcoming Limb Ischemia Clinical Trial

Sun, November 30, 2008

[ Sun, Nov 30th 2008 ] - Market Wire

Regulus Therapeutics, Alnylam Pharmaceuticals, an .. Ever In Vivo Efficacy Data for a microRNA Therap

Fri, November 28, 2008

[ Fri, Nov 28th 2008 ] - Market Wire

SCOR: SCOR establishes reinsurance subsidiary in Moscow

[ Fri, Nov 28th 2008 ] - Market Wire

Schaeffer's Early Edge: eBay, Eli Lilly, and Yahoo!

[ Fri, Nov 28th 2008 ] - Market Wire

MoneyTV; Mutual Merchant Services, Inc.; Imaging3 .. ca, Inc.; OriginOil, Inc.: MoneyTV, Week of 11/28

Thu, November 27, 2008

[ Thu, Nov 27th 2008 ] - Market Wire

Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal

[ Thu, Nov 27th 2008 ] - Market Wire

FORTIS: Herman Verwilst to Step Down From Fortis Board of Directors

[ Thu, Nov 27th 2008 ] - Market Wire

SORIN GROUP FIRMA ACCORDO DI ACQUISIZIONE DEL BUS .. ELIEVO ENDOSCOPICO DI VASI SANGUIGNI DA DATASCOPE

Wed, November 26, 2008

[ Wed, Nov 26th 2008 ] - Market Wire

Mentor to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Osiris Therapeutics to Present at 20th Annual Piper Jaffray Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Alliance Imaging to Present at the Piper Jaffray Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Micrus Endovascular to Present at Piper Jaffray 20th Annual Unplugged Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

MedaSorb Technologies Corporation: MedaSorb Techn .. Jones M.D., Elected President of the Renal Physi

[ Wed, Nov 26th 2008 ] - Market Wire

Psychiatric Solutions to Present at the JPMorgan SMid Cap Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Somatic Systems, Inc.: Somatic Systems, Inc. National Television Show Airings Begin

[ Wed, Nov 26th 2008 ] - Market Wire

Mannatech Congratulates Team Mannatech " Athletes on Recent Accomplishments

[ Wed, Nov 26th 2008 ] - Market Wire

Wyeth and Progenics Announce Positive Outcome of .. cutaneous RELISTOR for Opioid-Induced Constipatio

[ Wed, Nov 26th 2008 ] - Market Wire

Tarceva (erlotinib) Endorsed by the U.K. s Nati .. nd Clinical Excellence for Use in Patients with A

Tue, November 25, 2008

[ Tue, Nov 25th 2008 ] - Market Wire

Webcast Alert: Interview with Jay Higham, CEO, IntegraMed America

[ Tue, Nov 25th 2008 ] - Market Wire

Dynavax Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market

[ Tue, Nov 25th 2008 ] - Market Wire

Health Net Names Chief Medical Officer

[ Tue, Nov 25th 2008 ] - Market Wire

Abraxis BioScience Announces Agreement to Re-Acqu .. ABRAXANE; Company Highlights Plans to Initiate Ni

[ Tue, Nov 25th 2008 ] - Market Wire

Protalix BioTherapeutics to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Enrollment in Provectus Phase 2 Melanoma Clinical Trial Reaches Halfway Point

[ Tue, Nov 25th 2008 ] - Market Wire

Inspire Announces Webcast of Presentation at Piper Jaffray Conference

[ Tue, Nov 25th 2008 ] - Market Wire

Cytori Strengthens European Union Sales, Training and Service Operations

[ Tue, Nov 25th 2008 ] - Market Wire

Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare Conference

Mon, November 24, 2008

[ Mon, Nov 24th 2008 ] - Market Wire

Crucell N.V.: DSM Biologics and Crucell Announce .. PER.C6(R) Licensing Agreement with Gedeon Richter

[ Mon, Nov 24th 2008 ] - Alexa Nuessle

TEEN SUICIDES THIRD LEADING CAUSE OF DEATH Teen Suicide is a Preventable Public Health Problem

[ Mon, Nov 24th 2008 ] - Market Wire

New Noninvasive Prenatal Diagnostic Technology Al .. Diseases Such as Cystic Fibrosis Caused by Single

[ Mon, Nov 24th 2008 ] - Market Wire

DexCom to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Mon, Nov 24th 2008 ] - Market Wire

Roderick de Greef Named Chairman of Cambridge Heart Board of Directors

[ Mon, Nov 24th 2008 ] - Market Wire

U.S. FDA Grants Pralatrexate Orphan Drug Designat .. nt of Patients with Diffuse Large B-Cell Lymphoma

[ Mon, Nov 24th 2008 ] - Market Wire

Celsion Announces the Appointment of Sean Moran as Chief Financial Officer

[ Mon, Nov 24th 2008 ] - Market Wire

Genzyme Seeks U.S. Approval for Clolar to Treat Adult AML

[ Mon, Nov 24th 2008 ] - Market Wire

OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday,December 4th

[ Mon, Nov 24th 2008 ] - Market Wire

Medtronic Names Francine Kaufman, M.D. to Key Executive Role in Diabetes Business

[ Mon, Nov 24th 2008 ] - Market Wire

LifePoint Hospitals Names Michael S. Coggin Chief Accounting Officer

Thu, November 20, 2008

[ Thu, Nov 20th 2008 ] - Market Wire

HealthSpring, Inc. Announces Retirement of Chief Financial Officer, Kevin M. McNamara

[ Thu, Nov 20th 2008 ] - Market Wire

Solvay Pharmaceuticals, Inc. Announces Exclusive .. ent with Depomed, Inc. for Gabapentin GR® for th

[ Thu, Nov 20th 2008 ] - Market Wire

OSI Pharmaceuticals to Present at the Piper Jaffr .. alth Care Conference on Tuesday, December 2, 2008

[ Thu, Nov 20th 2008 ] - Market Wire

Chembio Diagnostics, Inc.: Chembio Ships First DPP(R) Tests

[ Thu, Nov 20th 2008 ] - Market Wire

Oscient Pharmaceuticals Announces Determination o .. the Consideration Issuable in its Exchange Offer

[ Thu, Nov 20th 2008 ] - Market Wire

OR-Live, Inc.: REMINDER: Prostate Cancer Treatmen .. Using Minimally Invasive Cutting Edge Technology

[ Thu, Nov 20th 2008 ] - Market Wire

Cougar Biotechnology Announces Initiation of Phas .. erone Acetate) in Advanced Breast Cancer Patients

[ Thu, Nov 20th 2008 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. /2Clinical Trial of Elesclomol in Prostate Cancer

[ Thu, Nov 20th 2008 ] - Market Wire

Alnylam Presents Pre-clinical Data from TTR Amyloidosis DevelopmentProgram

[ Thu, Nov 20th 2008 ] - Market Wire

Akorn Enters into a Five Year Contract Manufacturing Agreement toSupply an Ophthalmic Product

Wed, November 19, 2008

[ Wed, Nov 19th 2008 ] - Market Wire

Imaging3, Inc.: Imaging3 to Debut 3D Real-Time Im .. and Perspective Interface at the RSNA Trade Show

[ Wed, Nov 19th 2008 ] - Market Wire

Symbollon Pharmaceuticals, Inc.: Symbollon Initiates Sales of IoGen Through Web Site BuyIoGen.com

[ Wed, Nov 19th 2008 ] - Market Wire

El armazÃ³n de colÃ¡geno de ReGen Biologics r .. recomendacionespositivas del panel ortopÃ©dico

[ Wed, Nov 19th 2008 ] - Market Wire

Cutera to Present at the Piper Jaffray 20th Annual Health CareConference

[ Wed, Nov 19th 2008 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces the Establishment of Syneron China

[ Wed, Nov 19th 2008 ] - Market Wire

Sanguine Corporation: Sanguine Corporation Announ .. tent to Acquire an MRI Imaging Technology Company

[ Wed, Nov 19th 2008 ] - Market Wire

Inhibiton Therapeutics Announces the Addition of Aaron A. Grunfeld toIts Board of Directors

[ Wed, Nov 19th 2008 ] - Market Wire

Seven Investigator-Initiated Clinical Studies Announced

[ Wed, Nov 19th 2008 ] - Market Wire

Randomized Phase 2 Study of IMC-A12 for HER2-Expr .. dvancedBreast Cancer Commences Patient Enrollment

[ Wed, Nov 19th 2008 ] - Market Wire

GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer

Tue, November 18, 2008

[ Tue, Nov 18th 2008 ] - Market Wire

Lime Energy Co. Reports Capital Raise and Debt Reduction

[ Tue, Nov 18th 2008 ] - Market Wire

LifeVantage Corporation Announces 1Q FY 2009 Financial and OperatingResults

[ Tue, Nov 18th 2008 ] - Market Wire

FORTIS: Fortis holding statement on Belgian court ruling

[ Tue, Nov 18th 2008 ] - Market Wire

BioSpheres UFE Awareness Campaign Continues with NBC-TV Today ShowAppearance by Beverly Johnson

[ Tue, Nov 18th 2008 ] - Market Wire

FDA Extends METOZOLV"¢ ODT Review Date

[ Tue, Nov 18th 2008 ] - Market Wire

Salix Announces Issuance of U.S. Patent for Rifaximin

[ Tue, Nov 18th 2008 ] - Market Wire

Immunosyn Corporation Files 10-Q

[ Tue, Nov 18th 2008 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. e Piper Jaffray 20th Annual Healthcare Conference

[ Tue, Nov 18th 2008 ] - Market Wire

StemCells, Inc. Closes $20 Million Equity Financing

[ Tue, Nov 18th 2008 ] - Market Wire

Metcare of Florida Scores High Marks in DSS Research Survey on PatientSatisfaction

Mon, November 17, 2008

[ Mon, Nov 17th 2008 ] - Market Wire

Teva Completes Enrollment in Laquinimod Phase III Clinical Trial

Synta Pharmaceuticals to Participate in the RBC Capital Markets Healthcare Conference

_{//health-fitness.news-articles.net/content/2008/ .. e-rbc-capital-markets-healthcare-conference.html}
^{Published in Health and Fitness on Wednesday, December 3rd 2008 at 8:21 GMT by Market Wire}

LEXINGTON, Mass.--([ BUSINESS WIRE ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that President and CEO Safi Bahcall, Ph.D., will participate in a panel discussion titled Tackling Tumors at the 2008 RBC Capital Markets Healthcare Conference on Wednesday, December 10 at 1:30 pm (ET) at The Westin New York at Times Square.

A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. Synta has a partnership with GlaxoSmithKline for the joint development and commercialization of its lead investigational drug candidate, elesclomol, which is in a global, pivotal Phase 3 clinical trial for the treatment of metastatic melanoma. For more information, please visit [ www.syntapharma.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Tue, Dec 02nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra

[ Tue, Dec 02nd 2008 ] - Market Wire

Targeted Genetics: Targeted Genetics Realigns Pro .. Priorities and Implements Cost Reduction Measures

[ Mon, Dec 01st 2008 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics Announces Clinic .. 3921 to Be Presented at the 2008 American Society

[ Wed, Nov 26th 2008 ] - Market Wire

Osiris Therapeutics to Present at 20th Annual Piper Jaffray Health Care Conference

[ Wed, Nov 26th 2008 ] - Market Wire

Alnylam to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

AVANIR to Present at the Piper Jaffray 20th Annual Health Care Conference

[ Tue, Nov 25th 2008 ] - Market Wire

ARIAD to Present at the Piper Jaffray 20th Annual Healthcare Conference

[ Mon, Nov 24th 2008 ] - Market Wire

U.S. FDA Grants Pralatrexate Orphan Drug Designat .. nt of Patients with Diffuse Large B-Cell Lymphoma

[ Thu, Nov 20th 2008 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. /2Clinical Trial of Elesclomol in Prostate Cancer

[ Thu, Nov 20th 2008 ] - Market Wire

Alnylam Presents Pre-clinical Data from TTR Amyloidosis DevelopmentProgram

[ Wed, Nov 19th 2008 ] - Market Wire

Randomized Phase 2 Study of IMC-A12 for HER2-Expr .. dvancedBreast Cancer Commences Patient Enrollment

[ Wed, Nov 19th 2008 ] - Market Wire

GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer